Denali Therapeutics announced that results from its open-label Phase 1/2 trial of tividenofusp alfa for Hunter syndrome were published in the January 1, 2026 issue of The New England Journal of ...
Gynecologists long viewed bacterial vaginosis as solely a women’s issue — until a study that treated their male partners, too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback